NCT02395016 2024-04-04A Study of Nimotuzumab Combinated With Gemcitabine in K-RAS Wild-type Locally Advanced and Metastatic Pancreatic CancerBiotech Pharmaceutical Co., Ltd.Phase 3 Completed90 enrolled 18 charts